News
April 28, 2025 Novo Nordisk's obesity drug Wegovy debuts in Thailand Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local ...
Medscape Medical News, April 28, 2025 Novo Nordisk's Obesity Drug Wegovy Debuts in Thailand Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the ...
Share on Pinterest Wegovy resolved liver inflammation in nearly two-thirds of participants in a major clinical trial, twice the rate seen with placebo. Steve Christo-Corbis/Getty Images Wegovy ...
DEAR PEOPLE’S PHARMACY: I took Wegovy for a few months last fall until I was unable to find a pharmacy that could fill my prescription. They were all out of stock. I lost 17 pounds and my A1C ...
Novo Nordisk NOVO.B-3.93%decrease; red down pointing triangle said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a ...
Global wellness giant Weight Watchers has filed for bankruptcy, while weight-loss drug maker Novo Nordisk cut its full-year forecasts. Read more.
the maker of the weight-loss drug Wegovy. San Francisco-based Hims & Hers said the plan was to make obesity care “more accessible, more affordable and more connected” for Americans.
CVS Caremark has selected Novo Nordisk’s Wegovy as the preferred GLP-1 medication for its largest commercial template formularies, effective July 1. In March, Novo Nordisk launched NovoCare ...
Novo Nordisk (NVO) announced Friday that the U.S. Food and Drug Administration (FDA) accepted its marketing application for an oral formulation of its weight loss therapy Wegovy (semaglutide ...
Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo Nordisk, after negotiating a price cut with the company, along with Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results